- Home
- MAV vs DERM Comparison
MAV vs DERM Comparison
Compare MAV & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAV
- DERM
- Stock Information
- Founded
- MAV 2003
- DERM 2014
- Country
- MAV United States
- DERM United States
- Employees
- MAV N/A
- DERM N/A
- Industry
- MAV Finance Companies
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- MAV Finance
- DERM Health Care
- Exchange
- MAV Nasdaq
- DERM Nasdaq
- Market Cap
- MAV 184.1M
- DERM 174.7M
- IPO Year
- MAV N/A
- DERM 2021
- Fundamental
- Price
- MAV $8.40
- DERM $6.40
- Analyst Decision
- MAV
- DERM Strong Buy
- Analyst Count
- MAV 0
- DERM 2
- Target Price
- MAV N/A
- DERM $10.00
- AVG Volume (30 Days)
- MAV 66.2K
- DERM 79.2K
- Earning Date
- MAV 01-01-0001
- DERM 05-20-2025
- Dividend Yield
- MAV 4.30%
- DERM N/A
- EPS Growth
- MAV N/A
- DERM N/A
- EPS
- MAV N/A
- DERM N/A
- Revenue
- MAV N/A
- DERM $56,134,000.00
- Revenue This Year
- MAV N/A
- DERM $29.83
- Revenue Next Year
- MAV N/A
- DERM $54.88
- P/E Ratio
- MAV N/A
- DERM N/A
- Revenue Growth
- MAV N/A
- DERM N/A
- 52 Week Low
- MAV $6.37
- DERM $3.20
- 52 Week High
- MAV $8.34
- DERM $7.84
- Technical
- Relative Strength Index (RSI)
- MAV 64.89
- DERM 47.75
- Support Level
- MAV $8.11
- DERM $6.47
- Resistance Level
- MAV $8.53
- DERM $7.10
- Average True Range (ATR)
- MAV 0.09
- DERM 0.41
- MACD
- MAV 0.05
- DERM -0.10
- Stochastic Oscillator
- MAV 80.51
- DERM 10.32
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.